We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+1.39%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
AUM
$304M
AUM Growth
+$23.3M
Cap. Flow
+$22.5M
Cap. Flow %
7.38%
Top 10 Hldgs %
36.29%
Holding
363
New
24
Increased
32
Reduced
61
Closed
17
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAR icon
51
Marriott International
MAR
$91.5B
$1.29M 0.42%
12,849
-300
-2% -$30K
GOOG icon
52
Alphabet (Google) Class C
GOOG
$4.19T
$1.25M 0.41%
27,280
+2,560
+10% +$117K
FBIN icon
53
Fortune Brands Innovations
FBIN
$5.43B
$1.22M 0.4%
21,919
-2,632
-11% -$143K
EMLC icon
54
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$1.21M 0.4%
32,131
+854
+3% +$32K
HP icon
55
Helmerich & Payne
HP
$4.25B
$1.21M 0.4%
22,260
+2,050
+10% +$120K
PFE icon
56
Pfizer
PFE
$159B
$1.18M 0.39%
37,009
+6
+0% +$189
VRTX icon
57
Vertex Pharmaceuticals
VRTX
$137B
$1.15M 0.38%
8,950
GILD icon
58
Gilead Sciences
GILD
$181B
$1.04M 0.34%
14,725
+2,850
+24% +$190K
RMD icon
59
ResMed
RMD
$34.7B
$990K 0.33%
12,715
+1,375
+12% +$98.4K
WFC.PRJ.CL
60
DELISTED
Wells Fargo & Company
WFC.PRJ.CL
$945K 0.31%
+37,000
New +$967K
BPFHP
61
DELISTED
Boston Private Financial Holdings, Inc.
BPFHP
$945K 0.31%
36,418
+400
+1% +$10.3K
BNY
62
Bank of New York Mellon
BNY
$110B
$935K 0.31%
18,318
BBT.PRE.CL
63
DELISTED
BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C
BBT.PRE.CL
$922K 0.3%
+36,250
New +$921K
WELL icon
64
Welltower
WELL
$172B
$897K 0.29%
19,996
+12,250
+158% +$895K
NVO
65
Novo Nordisk
NVO
$202B
$881K 0.29%
41,100
-1,200
-3% -$24.2K
EW icon
66
Edwards Lifesciences
EW
$52B
$864K 0.28%
21,930
+900
+4% +$32.9K
AMGN icon
67
Amgen
AMGN
$234B
$851K 0.28%
4,942
-185
-4% -$30.1K
OXY icon
68
Occidental Petroleum
OXY
$59.1B
$829K 0.27%
13,848
-750
-5% -$45.9K
MMP
69
DELISTED
Magellan Midstream Partners, L.P.
MMP
$769K 0.25%
10,788
DUK icon
70
Duke Energy
DUK
$93.8B
$738K 0.24%
8,832
-100
-1% -$8.41K
BIVV
71
DELISTED
Bioverativ Inc. Common Stock
BIVV
$679K 0.22%
11,283
+3,992
+55% +$227K
STI.PRE.CL
72
DELISTED
SunTrust Banks, Inc.
STI.PRE.CL
$667K 0.22%
+26,000
New +$668K
TCF.PRB.CL
73
DELISTED
TCF Financial Corporation
TCF.PRB.CL
$652K 0.21%
+25,748
New +$653K
BAC icon
74
Bank of America
BAC
$436B
$643K 0.21%
26,490
EMB icon
75
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$631K 0.21%
5,520

Similar funds

American Research & Management Company's Q2 2017 Portfolio in Review

As of Q2 2017, American Research & Management Company held 363 positions worth $304M, up 8.3% from $281M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

American Research & Management Company deployed $22.5M of net new capital in Q2 2017, opening 24 new positions and adding to 32 existing holdings. Its largest new stake was PrivateBancorp, Inc. Capital Trust IV Trust Preferred: 228,076 shares worth $5.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was IBM, an estimated $868K trimmed.

  • American Research & Management Company's largest Q2 2017 buy was PrivateBancorp, Inc. Capital Trust IV Trust Preferred: 228,076 shares worth $5.7M.
  • American Research & Management Company added most to State Street SPDR ICE Preferred Securities ETF in Q2 2017, an estimated $5.38M increase.
  • American Research & Management Company's biggest Q2 2017 reduction was IBM, cutting an estimated $868K.
  • American Research & Management Company fully exited PrivateBancorp Inc in Q2 2017, selling an estimated $249K.
  • American Research & Management Company's ten largest holdings make up 36% of its $304M portfolio in Q2 2017.
  • American Research & Management Company opened 24 new positions and closed 17 in Q2 2017.
  • American Research & Management Company's portfolio value rose 8.3% quarter-over-quarter to $304M.

Based on American Research & Management Company's 13F filing for Q2 2017, filed 27 Jul 2017.